These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24711380)

  • 1. Erbin is a negative modulator of cardiac hypertrophy.
    Rachmin I; Tshori S; Smith Y; Oppenheim A; Marchetto S; Kay G; Foo RS; Dagan N; Golomb E; Gilon D; Borg JP; Razin E
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5902-7. PubMed ID: 24711380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.
    Rachmin I; Amsalem E; Golomb E; Beeri R; Gilon D; Fang P; Nechushtan H; Kay G; Guo M; Yiqing PL; Foo RS; Fisher DE; Razin E; Tshori S
    Int J Cardiol; 2015 Sep; 195():85-94. PubMed ID: 26025865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmoglein-1/Erbin interaction suppresses ERK activation to support epidermal differentiation.
    Harmon RM; Simpson CL; Johnson JL; Koetsier JL; Dubash AD; Najor NA; Sarig O; Sprecher E; Green KJ
    J Clin Invest; 2013 Apr; 123(4):1556-70. PubMed ID: 23524970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone inhibits ERK phosphorylation in pressure overload-induced hypertrophied mouse hearts through a receptor-mediated mechanism.
    Suarez J; Scott BT; Suarez-Ramirez JA; Chavira CV; Dillmann WH
    Am J Physiol Cell Physiol; 2010 Dec; 299(6):C1524-9. PubMed ID: 20926779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erbin suppresses the MAP kinase pathway.
    Huang YZ; Zang M; Xiong WC; Luo Z; Mei L
    J Biol Chem; 2003 Jan; 278(2):1108-14. PubMed ID: 12379659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
    Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
    J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin K knockout alleviates pressure overload-induced cardiac hypertrophy.
    Hua Y; Xu X; Shi GP; Chicco AJ; Ren J; Nair S
    Hypertension; 2013 Jun; 61(6):1184-92. PubMed ID: 23529168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erbin inhibits RAF activation by disrupting the sur-8-Ras-Raf complex.
    Dai P; Xiong WC; Mei L
    J Biol Chem; 2006 Jan; 281(2):927-33. PubMed ID: 16301319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erbin regulates mitogen-activated protein (MAP) kinase activation and MAP kinase-dependent interactions between Merlin and adherens junction protein complexes in Schwann cells.
    Rangwala R; Banine F; Borg JP; Sherman LS
    J Biol Chem; 2005 Mar; 280(12):11790-7. PubMed ID: 15659388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adapter molecule DOC-2 is differentially expressed in pressure and volume overload hypertrophy and inhibits collagen synthesis in cardiac fibroblasts.
    Kumbar DH; VanBergen A; Ocampo C; Muangmingsuk S; Griffin AJ; Gupta M
    J Appl Physiol (1985); 2007 May; 102(5):2024-32. PubMed ID: 17255372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Adrenergic receptor stimulation causes cardiac hypertrophy via a Gβγ/Erk-dependent pathway.
    Vidal M; Wieland T; Lohse MJ; Lorenz K
    Cardiovasc Res; 2012 Nov; 96(2):255-64. PubMed ID: 22843704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
    Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
    Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
    Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
    J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tax1 enhances cancer cell proliferation via Ras-Raf-MEK-ERK signaling pathway.
    Song C; Wang W; Li M; Liu Y; Zheng D
    IUBMB Life; 2009 Jun; 61(6):685-92. PubMed ID: 19472191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role Played by Transcription Factor E3 in Modulating Cardiac Hypertrophy.
    Rishiq A; Islam O; Golomb E; Gilon D; Smith Y; Savchenko I; Eliaz R; Foo RS; Razin E; Tshori S
    Int Heart J; 2021 Nov; 62(6):1358-1368. PubMed ID: 34744144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compensation of the AKT signaling by ERK signaling in transgenic mice hearts overexpressing TRIM72.
    Ham YM; Mahoney SJ
    Exp Cell Res; 2013 Jun; 319(10):1451-62. PubMed ID: 23567182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of miR-21 is involved in direct actions of ursolic acid on the heart: implications for cardiac fibrosis and hypertrophy.
    Dong X; Liu S; Zhang L; Yu S; Huo L; Qile M; Liu L; Yang B; Yu J
    Cardiovasc Ther; 2015 Aug; 33(4):161-7. PubMed ID: 25903305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Erbin interlinking MuSK and ErbB2 and its impact on acetylcholine receptor aggregation at the neuromuscular junction.
    Simeone L; Straubinger M; Khan MA; Nalleweg N; Cheusova T; Hashemolhosseini S
    J Neurosci; 2010 May; 30(19):6620-34. PubMed ID: 20463225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raf-1 kinase is required for cardiac hypertrophy and cardiomyocyte survival in response to pressure overload.
    Harris IS; Zhang S; Treskov I; Kovacs A; Weinheimer C; Muslin AJ
    Circulation; 2004 Aug; 110(6):718-23. PubMed ID: 15289381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.